ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,064Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 6969

$908K Total Retail Price of All Prescriptions

Rank: 167 out of 6969

1,177 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 1,177 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

20% of this provider’s 1,177 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 16,311 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 827 622 S3 1 3
FUROSEMIDE 605 515 2 10
LEVOTHYROXINE SODIUM 543 511 3 5
AMLODIPINE BESYLATE 536 479 4 4
OMEPRAZOLE 440 334 5 6
SIMVASTATIN 423 388 6 1
LISINOPRIL 350 331 7 2
WARFARIN SODIUM 339 282 8 20
METOPROLOL TARTRATE 313 254 9 13
FAMOTIDINE 302 252 10 37
CARVEDILOL 276 248 11 25
GABAPENTIN 275 180 12 17
METFORMIN HCL 245 224 13 7
RANITIDINE HCL 242 193 14 46
CITALOPRAM HBR 233 221 15 34
PANTOPRAZOLE SODIUM 227 208 16 31
RISPERIDONE 224 217 17 88
LEVETIRACETAM 220 161 18 128
DONEPEZIL HCL 214 211 19 32
PAROXETINE HCL 206 156 20 65
ZOLPIDEM TARTRATE 204 159 21 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 200 176 22 114
SERTRALINE HCL 200 176 22 38
BENAZEPRIL HCL 197 174 24 18
PREDNISONE 177 142 25 70
ATENOLOL 176 144 26 9
ALBUTEROL SULFATE 174 83 27 123
HEPARIN SODIUM 172 89 28 302
IPRATROPIUM BROMIDE 171 87 29 179
LANTUS 171 129 29 50
LEVOFLOXACIN 167 129 31 109
PRAVASTATIN SODIUM 166 149 32 19
POTASSIUM CHLORIDE 152 135 33 30
TRAZODONE HCL 151 128 34 47
CLONIDINE HCL 147 122 35 59
BACLOFEN 147 58 35 86
FENTANYL 141 83 S2 37 113
AMOXICILLIN 135 113 38 99
KLOR-CON 10 133 112 39 160
GLIPIZIDE 133 125 39 21
DIGOXIN 131 105 41 71
QUETIAPINE FUMARATE 131 84 41 101
METOCLOPRAMIDE HCL 124 71 43 136
CLOPIDOGREL 123 116 44 48
LOSARTAN POTASSIUM 118 99 45 12
DIVALPROEX SODIUM 112 89 46 103
TAMSULOSIN HCL 111 110 47 23
ATORVASTATIN CALCIUM 110 79 48 11
LOVASTATIN 109 109 49 15
COMBIVENT 107 83 50 170
CARBIDOPA-LEVODOPA 106 98 51 119
ADVAIR DISKUS 106 97 51 45
OXYCODONE-ACETAMINOPHEN 105 63 S2 53 135
IPRATROPIUM-ALBUTEROL 104 92 54 212
FLUOXETINE HCL 102 98 55 43
GLIMEPIRIDE 100 89 56 44
TRAMADOL HCL 97 79 57 27
KLOR-CON M20 92 63 58 201
ALLOPURINOL 92 67 58 35
NAMENDA 91 87 60 51
MEGESTROL ACETATE 87 82 R 61 129
CIPROFLOXACIN HCL 86 76 62 64
TRIAMTERENE-HCTZ 86 71 62 58
PROAIR HFA 86 51 62 33
ENALAPRIL MALEATE 84 84 65 56
MIRTAZAPINE 84 78 65 76
MORPHINE SULFATE ER 83 71 S2 67 90
HUMALOG 83 73 67 167
KLOR-CON M10 80 78 69 257
HUMULIN R 80 64 69 223
PROMETHAZINE HCL 78 49 R 71 203
VERAPAMIL ER 77 77 72 133
HYDROCHLOROTHIAZIDE 75 75 73 8
ACETAMINOPHEN-CODEINE 72 57 S3 74 73
LACTULOSE 72 54 74 131
NYSTATIN 71 59 76 215
TRANSDERM-SCOP 71 52 76 478
CEPHALEXIN 71 62 76 96
NOVOLOG 71 61 76 166
TERAZOSIN HCL 71 60 76 49
PHENYTOIN SODIUM EXTENDED 69 66 81 169
HYDROMORPHONE HCL 67 14 S2 82 188
METRONIDAZOLE 66 61 83 316
GLYBURIDE 66 66 R 83 54
OXYBUTYNIN CHLORIDE 66 62 83 126
TRIAMCINOLONE ACETONIDE 65 57 86 55
FINASTERIDE 65 65 86 80
HYDRALAZINE HCL 64 49 88 106
SEROQUEL 63 26 89 205
ALENDRONATE SODIUM 62 61 90 14
SANTYL 62 52 90 280
FLUTICASONE PROPIONATE 59 59 92 24
MELOXICAM 59 58 92 36
ENDOCET 58 51 S2 94 355
PLAVIX 58 53 94 68
LORAZEPAM 58 48 94 186
SPIRONOLACTONE 58 51 94 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 41 98 28
IBUPROFEN 56 45 99 29
GLYCOPYRROLATE 56 24 99 383
SPIRIVA 56 52 99 66
POLYETHYLENE GLYCOL 3350 55 34 102 127
VENTOLIN HFA 55 21 102 125
VENLAFAXINE HCL ER 54 0 104 150
NOVOLIN R 53 47 105 161
DILTIAZEM HCL 52 41 106 342
NEXIUM 51 42 107 52
NITROFURANTOIN MONO-MACRO 51 49 107 216
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.